Evidence map›Paper›PMID 39800207›Full record

ArticleInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2025

A large geno-spatial cluster of multi-drug resistant tuberculosis outbreak in a western district of Thailand.

Natthakan Thipkrua, Areeya Disrathakit, Virasakdi Chongsuvivatwong, Surakameth Mahasirimongkol, Wuthiwat Ruangchai, Prasit Palittapongarnpim, Angkana Chaiprasert, Petchawan Pungrassami, Phalin Kamolwat, Krairerk Suthum and 2 more

Abstract read
In one paragraph

Article in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Natthakan ThipkruaDepartment of Epidemiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand; Office of Prevention and Control Disease region 5, Ratchaburi, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand. Electronic address: natthakantip@gmail.com.
Areeya DisrathakitMedical Genetics Center, Department of Medical Sciences, Ministry of Public Health, Bangkok, Thailand. Electronic address: areeyadis@yahoo.com.
Virasakdi ChongsuvivatwongDepartment of Epidemiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand. Electronic address: cvirasak@medicine.psu.ac.th.
Surakameth MahasirimongkolMedical Genetics Center, Department of Medical Sciences, Ministry of Public Health, Bangkok, Thailand.
Wuthiwat RuangchaiPornchai Matangkasombut Center for Microbial Genomics, Department of Microbiology, Faculty of Science, Mahidol University, Bangkok, Thailand. Electronic address: r.wuthiwat@gmail.com.
Prasit PalittapongarnpimPornchai Matangkasombut Center for Microbial Genomics, Department of Microbiology, Faculty of Science, Mahidol University, Bangkok, Thailand. Electronic address: prasit.pal@mahidol.ac.th.
Angkana ChaiprasertOffice for Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Electronic address: angkana.cha@mahidol.ac.th.
Petchawan PungrassamiDivision of Tuberculosis, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand. Electronic address: petchpungrassami@gmail.com.
Phalin KamolwatDivision of Tuberculosis, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand. Electronic address: drphalin09@gmail.com.
Krairerk SuthumOffice of Prevention and Control Disease region 5, Ratchaburi, Department of Disease Control, Ministry of Public Health, Bangkok, Thailand. Electronic address: krairerksu@gmail.com.
Koapong TossapornpongMakarak Hospital, Tha Maka district, Kanchanaburi province, Thailand. Electronic address: korpong@gmail.com.
Hutcha SriplungDepartment of Epidemiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand. Electronic address: hutcha.s@gmail.com.

Funding

TB/MDR-TB Research training and Capacity Strengthening for LMIC in Southeast Asia Phase II: Promotion of Diversity, Equity and Inclusion (DEI)D43TW009522 · FIC · PRINCE OF SONGKLA UNIVERSITY · PI Virasakdi Chongsuvivatwong · 2015 to 2026
$3.0M
FIC NIH HHS D43 TW009522
6 · The paper itself

Abstract

The growing issue of drug resistance, particularly multidrug-resistant TB (MDR-TB), has exacerbated this problem. The rise of drug resistance TB is a severe global health concern. In Thailand, a persistent community outbreak of primary MDR-TB has been confirmed in the Tha Maka district of Kanchanaburi province, with an increasing prevalence of MDR-TB among newly diagnosed pulmonary tuberculosis cases. It was the first site in Thailand where a cluster of MDR-TB, caused by the Asian African 3 Modern Beijing strain, and XDR-TB, caused by L2.1, outbreaks were reported. This study aims to assess the MDR-TB outbreak in detail by characterizing the genomic profiles of the prevalent MDR-TB strains and examining their geographical distribution within the affected district. Through whole-genome sequencing (WGS) and bioinformatic analysis of 188 MTB isolates, the study identified three major phylogenetic lineages: the East Asian lineage (L2, 92 %), the Indo-Oceanic lineage (L1, 5.9 %), and the Euro-American lineage (L4, 2.1 %). The detailed sub-lineage distribution offers valuable insights into the predominant genetic clusters of M. tuberculosis within the sampled population. Notably, Lineage 2, specifically the L2.2.M3 sub-lineage, stood out as the dominant strain of MDR-TB, accounting for 77.7 % of the isolates. This finding underscores the significant prevalence of the L2.2.M3 sub-lineage and its potential role in the local transmission dynamics of tuberculosis. The high proportion and genetic homogeneity of the L2.2.M3 cluster among MDR-TB patients may indicate the strain's adaptation for more effective transmission within the Thai population. The increasing prevalence of this pathogenic strain could significantly impact tuberculosis control programs. Early diagnosis and contact tracing with chemotherapeutic preventive therapy for MDR-TB will be essential in inhibiting the spread and reactivation of these strains. Additionally, further studies are needed to prospectively identify transmission routes through contact tracing and real-time genotypic methods. It will also be crucial to ensure that future vaccines and/or recommended chemoprophylaxis therapy for MDR-TB will provide protection against these emerging strains.

Indexed as

Disease OutbreaksMycobacterium tuberculosisTuberculosis, Multidrug-ResistantAdolescentAdultDrug Resistance, Multiple, BacterialFemaleGenome, BacterialGenotypeHumansMaleMiddle AgedPhylogenyThailandWhole Genome SequencingYoung AdultGeno-spatialMultidrug-resistant tuberculosisSingle nucleotide polymorphismTuberculosis outbreakWhole genome sequencing

Identifiers

PMID39800207
PMCPMC12381799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.